RACHEL MATHISEN: Open Payments
NPI 1679009724 · WAGENER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 7 payments from 5 companies in 2025. Trend: 2023 $530 · 2024 $759 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $247 |
| Lilly USA, LLC | 2 | $208 |
| AstraZeneca Pharmaceuticals LP | 1 | $111 |
| Tris Pharma Inc | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: CAPLYTA, LOKELMA, KISUNLA, ZEPBOUND, Dyanavel XR.
Industry payments across SC — which companies pay providers there.
